Mesoblast Limited: FDA Acknowledges Effects on Pain Intensity Favor Rexlemestrocel-L, Confirms 12-Month Reduction in Back Pain Supports Product Efficacy

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided feedback received from the ...

Basivertebral nerve ablation provides early, sustained chronic low back pain relief

Chronic low back pain significantly affects quality of life for millions of people worldwide. Back pain makes it difficult to ...

Treatments for low back pain can cost thousands—but some of the best fixes are free

Among the myriad of medical treatments for low back pain—a leading cause of disability that affects more than 600 million ...